What are the Wegovy pill doses?
1.5mg, 4mg, 9mg and 25mg. One Wegovy pill daily, stepping up once every 30 days, depending on your tolerance and appetite suppression. We move through the doses at a pace guided by how your body responds. The Wegovy pill dosage chart below shows the standard Wegovy pill dosage schedule:
| Month | Days | Wegovy pill dose | Tablets per day | Purpose |
| 1 | 1-30 | 1.5mg | 1 | Adaptation |
| 2 | 31-60 | 4mg | 1 | Stepping up |
| 3 | 61-90 | 9mg | 1 | Stepping up |
| 4 onwards | 91 onwards | 25mg | 1 | Full maintenance dose |
The Wegovy pill milligrams look much higher than the Wegovy pen doses. That is down to differences in absorption, not potency. A tablet passes through your digestive system, and your body absorbs less semaglutide that way. Each Wegovy pill needs to be larger to make up the difference.
The active ingredient in every Wegovy pill is semaglutide, a glucagon-like peptide (GLP-1) receptor agonist. This is often called a GLP-1 for short. It works by copying a hormone your gut naturally produces after eating. That hormone tells your brain you are full and slows down how quickly your stomach empties.
Each of the four Wegovy pill strengths pairs semaglutide with a coating called SNAC. SNAC is what carries the medicine through your stomach lining and into your bloodstream. Understanding how the Wegovy pill works at the absorption level explains why the rules around taking it matter.
Why does the Wegovy pill start at a low dose?
1.5 mg is an important first step in treatment, chosen to build tolerance. Giving your body time to adjust to the medication before increasing the dose will help prevent potentially serious side effects. Without those first few weeks on a lower dose, jumping straight to 25mg would cause severe nausea and vomiting. We structure the dosages for the Wegovy pill to avoid this. Most people will not see meaningful weight loss at this stage.
Each treatment step is 30 days, taking one tablet per day. As you come to the end of each step, consider how you have responded. If side effects are still difficult or if appetite suppression is very strong, you may want to hold off a dose increase. The Wegovy pill dose escalation follows a monthly pattern, but the pace is flexible. Rushed escalation helps nobody.
In the OASIS 4 trial, around 7 in 100 people stopped the Wegovy pill because of side effects. Only about 3 in 100 stopped specifically because of stomach-related symptoms. Those figures are low, likely because the trial participants had regular clinical support.
How do you take the Wegovy pill?
Take one tablet on an empty stomach, first thing in the morning. No more than 120ml of plain water. Swallow the tablet whole.
Do not crush, chew or split it. Then wait at least 30 minutes before eating, drinking anything else or taking other medicines by mouth.
Unlike the injections, Wegovy tablets need an empty stomach and a controlled water volume to work properly.
Break any of those rules and absorption drops, often to zero. Food, coffee, excess water or a partially full stomach all interfere with the SNAC coating. How to take the Wegovy pill correctly is a medical requirement, not a preference.
What is the Wegovy pill maintenance dose?
The Wegovy pill maintenance dose is 25mg once daily. This is the highest Wegovy tablet strength available and the dose tested in the OASIS 4 trial. At this dose, semaglutide levels in your blood are comparable to the 2.4mg weekly injection.
The OASIS 1 trial also studied a 50 mg dose. It appeared to cause more side effects, but the extra weight loss was not enough to justify them.
What does daily life at 25 mg look like?
Your daily routine will stay the same, but it should be easier. Same tablet, empty stomach, 30-minute wait before breakfast. The difference is in how you feel.
Appetite is more consistently managed. Side effects from earlier Wegovy doses have usually settled. For most people, the medicine becomes part of their morning routine.
In the OASIS 4 trial, people taking 25 mg lost an average of around 14% of their body weight over 64 weeks. At a starting weight of 106kg, that is roughly a 14-15kg loss.
Around 1 in 4 participants did not reach 5% weight loss. The most common reason was inconsistent use. If your weight loss slows or stalls after several months, we can review what might be contributing.
Join now
Is the Wegovy pill suitable for everyone?
No. Oral Wegovy is not suitable for people with a personal or family history of medullary thyroid cancer. A condition called MEN 2, pregnancy and breastfeeding are other exclusions to treatment.
Certain patients may require specialist services to access this medication. If you have a history of pancreatitis, severe kidney problems or diabetic eye disease, you may still be a candidate. However, extra monitoring would be needed. In some cases, the risks outweigh the benefits.
If you have type 2 diabetes, make sure your diabetic clinic or GP knows you are planning to start a GLP-1. For people already on diabetes medicines, doses often need adjusting before starting on semaglutide. This prevents blood sugar levels from becoming too low. We assess your full medical history before starting treatment, so let us know on the consultation form if you are diabetic and which medications you are taking.
Who is it designed for? Adults with a BMI of 30 or above, or 27 and above where a weight-related health condition is also present. High blood pressure, type 2 diabetes and high cholesterol are the most common qualifiers. We check that you meet these criteria and that the medicine is right for you before issuing a prescription.
What if I miss a Wegovy pill dose?
If you miss a Wegovy pill dose, skip the missed dose and take your next tablet the following morning. Do not take two tablets to make up for it. Semaglutide stays in your system for roughly a week, so one missed dose at the maintenance stage barely changes your blood levels.
If you are missing Wegovy pill doses regularly, that is where results start slipping. You may notice your appetite returning a bit sooner than usual, or feeling slightly less controlled around food. Do not take extra tablets to try and “catch up”. Resume your normal dose the next morning.
If a full week or more has passed without the medicine, get in touch with our clinical team before restarting. The dosing schedule for the Wegovy pill assumes daily use, and a gap that long may mean we need to review your current dose.
Most people who miss doses do so because their routine has changed. Keeping the tablets somewhere visible and taking them at the same time each day builds the habit.
How long do I need to take the Wegovy pill?
Oral Wegovy treatment has no fixed endpoint. The World Obesity Federation recognises obesity as a chronic relapsing condition. The comparison with blood pressure medication is useful here.
Those tablets keep your blood pressure where it needs to be. Stop taking them, and it rises again. Semaglutide works the same way for appetite.
The STEP 1 trial extension tracked what happened after people stopped it. Within 12 months, participants regained roughly two-thirds of the weight they had lost. A 2026 BMJ review of 37 studies and over 9,300 people across different weight loss treatments found the same pattern.
The STEP 5 trial instead followed people who stayed on the medicine for two full years. Weight loss was maintained throughout, and the medicine remained safe and effective over that period.
The UK National Institute for Health and Care Excellence (NICE) recommends a maximum of two years on the NHS. That limit is based on how the treatment was assessed for NHS funding, not on evidence that the medicine stops working after two years. Privately funded treatment can continue where appropriate, with no limits.
How long to take the Wegovy pill depends on individual response, not a calendar. Some people find the return of old hunger patterns difficult after months of reduced appetite. A planned approach beats stopping your weight loss medication suddenly.
What if I cannot tolerate the 25mg dose?
If the 25 mg Wegovy pill dose is not tolerable, stopping treatment is not the only option. Alternatives are worth trying first.
If the 25mg Wegovy pill dose is not tolerable, stopping treatment is not the only option. The most common first step is staying on the previous dose for longer than 30 days, then trying the higher dose again once symptoms have settled.
If the oral route itself remains difficult, the prescribing guidance includes a fallback: switching to the Wegovy pen at 1.7mg per week. The injection avoids the stomach irritation caused by the tablet coating, but nausea linked to how semaglutide slows digestion can still happen with either format. If you are finding a dose step difficult, let us know, and we can advise on the best next step for you.
When should I see a doctor?
Stomach-related side effects of Wegovy pills, such as nausea, vomiting, diarrhoea and constipation, are common during dose escalation. These effects can improve over time as your body’s tolerance to semaglutide builds. If side effects are difficult to manage during the dosage schedule, we can adjust the pace to suit you.
Some symptoms need urgent attention regardless of where you are in the Wegovy pill dosing schedule.
Pancreatitis. Severe stomach pain that will not ease, particularly if it spreads to your back, can be a sign of pancreatitis. This is rare but serious. Dial 999 or go to A&E. Do not wait to see if it passes.
Gallstones. Sharp pain under the right ribs, usually after eating, can signal gallstones. Rapid weight loss can trigger them regardless of the method. Contact your GP or our clinical team for assessment.
Sudden vision loss. In February 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a safety warning linking semaglutide to a very rare eye condition called non-arteritic anterior ischaemic optic neuropathy (NAION). This typically causes sudden, painless vision loss or rapidly worsening eyesight in one eye. If you notice any sudden change in your vision while taking the Wegovy pill, go to eye casualty or A&E urgently.
Hair loss. Some people notice hair thinning during periods of rapid weight loss. This is often linked to lower calorie intake rather than semaglutide itself, and in most cases, hair regrows over time. If hair loss is persistent or severe, see your doctor. They can rule out other causes and check your blood levels.
Mood changes. If you or someone close to you notices changes in your mood, persistent low mood, or any thoughts of self-harm while taking the Wegovy pill, contact your GP or our clinical team straight away. If you are experiencing suicidal thoughts, go to A&E and ask for the CRISIS team. These reports are uncommon with semaglutide, but they are taken seriously and should not be dismissed.
Any side effect that is persistent, severe or affecting your daily life is worth raising with us. A dose adjustment or temporary hold is nearly always a better path than stopping treatment on your own.
Frequently asked questions
Can I switch between the Wegovy pill and the injection?
Yes, switching between the Wegovy pill and the Wegovy injection is possible with clinical oversight. The Wegovy pill dose chart and Wegovy pen schedule use different structures, so we map you to the correct strength.
Do the Wegovy pill doses affect blood sugar?
Semaglutide can lower blood sugar levels. For people without diabetes, this is unlikely to cause any problems. If you are already taking diabetes medicines, your GP or diabetes clinic may need to adjust those when Wegovy pills start, and again as treatment progresses, to keep blood sugar levels stable.
Do I need to diet and increase physical activity?
Wegovy pills should be taken alongside a reduced-calorie diet and increased physical activity. The strongest weight loss results came from people who stuck with changes to their diet and activity levels over the longer term.
Are common side effects worse at the higher Wegovy pill doses?
Stomach-related side effects tend to peak during escalation, but usually settle down by the time you reach the 25mg Wegovy pill dosing schedule stage. Most were mild to moderate in OASIS 4.
What Wegovy pill form doses are available?
Four tablets: 1.5mg, 4mg, 9mg and 25mg. The Wegovy pill mg you take increases as you step through treatment. Dosing for Wegovy pill follows the schedule in the table above, and we issue a new prescription at each step.
Key takeaways
- Oral Wegovy comes in four strengths, stepping up monthly. The Wegovy pill dosage schedule reaches 25 mg by month four, but this is flexible.
- Weight loss at 25mg averaged 14% over 64 weeks. One in four did not reach a clinically meaningful loss. Inconsistent use was the main reason.
- Oral Wegovy is not suitable for everyone. Eligibility is assessed before treatment starts.
- Stopping semaglutide leads to weight regain. Alternatives exist if 25mg is not tolerable.
References
A New Era for Oral Peptides: SNAC and the Development of Oral Semaglutide for the Treatment of Type 2 Diabetes, Review of Endocrine and Metabolic Disorders [Accessed 12 April 2026].
Oral Semaglutide 25 mg in Adults with Overweight or Obesity (OASIS 4), New England Journal of Medicine, 2025 [Accessed 12 April 2026].
Oral Semaglutide 50 mg Taken Once Per Day in Adults with Overweight or Obesity (OASIS 1), The Lancet, 2023 [Accessed 12 April 2026].
WEGOVY (semaglutide) Tablets Prescribing Label, NDA 218316, U.S. Food and Drug Administration [Accessed 12 April 2026].
Obesity: A Chronic Relapsing Progressive Disease Process. A Position Statement of the World Obesity Federation, Obesity Reviews [Accessed 12 April 2026].
Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension, Diabetes, Obesity and Metabolism [Accessed 12 April 2026].
Weight Regain After Cessation of Medication for Weight Management: Systematic Review and Meta-Analysis, BMJ, 2026 [Accessed 12 April 2026].
Two-Year Effects of Semaglutide in Adults with Overweight or Obesity: The STEP 5 Trial, Nature Medicine [Accessed 12 April 2026].
Semaglutide for Managing Overweight and Obesity: Technology Appraisal Guidance TA875, National Institute for Health and Care Excellence (NICE), Published 8 March 2023 [Accessed 12 April 2026].
Semaglutide (Wegovy, Ozempic and Rybelsus): Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), MHRA Drug Safety Update, February 2026 [Accessed 12 April 2026].
Authorship

Authored by Shereen Amin
Pharmacist Independent Prescriber & Medical Writer
GPhC: 2073003
Shereen is a Pharmacist Independent Prescriber and medical writer with over ten years' experience across NHS primary care, digital health and specialist services. She writes evidence-based health content for Simple Online Pharmacy, turning complex clinical information into guidance patients can actually use.

Medically Reviewed by Richard Wood
Pharmacist / Clinical Specialist
GPhC reg:
2078802
Richard is a pharmacist and content reviewer at Simple Online Pharmacy. He officially joined the team in 2024 after several years of working with the company as a contractor. Prior to that, he spent over 11 years as a community pharmacist, building a strong foundation in patient care.